Clinical trials
Phase 1/2 Ischemic Stroke trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 6 |
| Withdrawn | 5 |
| Not yet recruiting | 5 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xuanwu Hospital, Beijing | 4 |
| Capital Medical University | 2 |
| ImaRx Therapeutics | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| Acticor Biotech | 1 |
| Affiliated Hospital of Nantong University | 1 |
| Ajou University School of Medicine | 1 |
| Andrew Slivka | 1 |
| Baylor College of Medicine | 1 |
| Burke Medical Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 51 |
| Stroke | 16 |
| Ischemia | 4 |
| Brain Infarction | 2 |
| Hemorrhage | 2 |
| Brain Injuries, Traumatic | 1 |
| Cerebral Hemorrhage | 1 |
| Cerebral Infarction | 1 |
| Cerebral Palsy | 1 |
| Cough | 1 |
Trials
Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.